Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 223

1.

Microglial activation induced by factor(s) contained in sera from Alzheimer-related ApoE genotypes.

Lombardi VR, García M, Cacabelos R.

J Neurosci Res. 1998 Nov 15;54(4):539-53.

PMID:
9822164
2.

APOE-induced microglial activation: an in vitro assay to screen sera from Alzheimer's disease patients and novel therapeutic compounds.

Lombardi VR, García M, Cacabelow R.

Methods Find Exp Clin Pharmacol. 1998 Jun;20(5):377-86.

PMID:
9701775
3.

Microglial activation in Alzheimer disease: Association with APOE genotype.

Egensperger R, Kösel S, von Eitzen U, Graeber MB.

Brain Pathol. 1998 Jul;8(3):439-47.

PMID:
9669695
4.

A polymorphic variation in the interleukin 1A gene increases brain microglial cell activity in Alzheimer's disease.

Hayes A, Green EK, Pritchard A, Harris JM, Zhang Y, Lambert JC, Chartier-Harlin MC, Pickering-Brown SM, Lendon CL, Mann DM.

J Neurol Neurosurg Psychiatry. 2004 Oct;75(10):1475-7.

5.

Changes in apolipoprotein E expression in response to dietary and pharmacological modulation of cholesterol.

Petanceska SS, DeRosa S, Sharma A, Diaz N, Duff K, Tint SG, Refolo LM, Pappolla M.

J Mol Neurosci. 2003;20(3):395-406.

PMID:
14501024
6.

Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.

Davidson Y, Gibbons L, Pritchard A, Hardicre J, Wren J, Tian J, Shi J, Stopford C, Julien C, Thompson J, Payton A, Thaker U, Hayes AJ, Iwatsubo T, Pickering-Brown SM, Pendleton N, Horan MA, Burns A, Purandare N, Lendon CL, Neary D, Snowden JS, Mann DM.

J Neurol Neurosurg Psychiatry. 2006 Apr;77(4):515-7.

7.

Human apoE3 but not apoE4 rescues impaired astrocyte activation in apoE null mice.

Ophir G, Meilin S, Efrati M, Chapman J, Karussis D, Roses A, Michaelson DM.

Neurobiol Dis. 2003 Feb;12(1):56-64.

PMID:
12609489
9.

Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.

Premkumar DR, Cohen DL, Hedera P, Friedland RP, Kalaria RN.

Am J Pathol. 1996 Jun;148(6):2083-95.

10.
11.

Endogenous apolipoprotein E suppresses LPS-stimulated microglial nitric oxide production.

Laskowitz DT, Matthew WD, Bennett ER, Schmechel D, Herbstreith MH, Goel S, McMillian MK.

Neuroreport. 1998 Mar 9;9(4):615-8.

PMID:
9559926
12.

APOE and the regulation of microglial nitric oxide production: a link between genetic risk and oxidative stress.

Colton CA, Brown CM, Cook D, Needham LK, Xu Q, Czapiga M, Saunders AM, Schmechel DE, Rasheed K, Vitek MP.

Neurobiol Aging. 2002 Sep-Oct;23(5):777-85.

PMID:
12392781
13.

Neuronal Regulation of Neuroprotective Microglial Apolipoprotein E Secretion in Rat In Vitro Models of Brain Pathophysiology.

Polazzi E, Mengoni I, Peña-Altamira E, Massenzio F, Virgili M, Petralla S, Monti B.

J Neuropathol Exp Neurol. 2015 Aug;74(8):818-34. doi: 10.1097/NEN.0000000000000222.

PMID:
26185969
14.

Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.

Martínez-Morillo E, Hansson O, Atagi Y, Bu G, Minthon L, Diamandis EP, Nielsen HM.

Acta Neuropathol. 2014 May;127(5):633-43. doi: 10.1007/s00401-014-1266-2. Epub 2014 Mar 15.

PMID:
24633805
15.

APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism.

Kamboh MI, Sanghera DK, Ferrell RE, DeKosky ST.

Nat Genet. 1995 Aug;10(4):486-8. Erratum in: Nat Genet 1995 Sep;11(1):104.

PMID:
7670501
16.

Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease.

Reynolds WF, Rhees J, Maciejewski D, Paladino T, Sieburg H, Maki RA, Masliah E.

Exp Neurol. 1999 Jan;155(1):31-41.

PMID:
9918702
17.

Association between apolipoprotein E e4 allele and arteriosclerosis, cerebral amyloid angiopathy, and cerebral white matter damage in Alzheimer's disease.

Tian J, Shi J, Bailey K, Lendon CL, Pickering-Brown SM, Mann DM.

J Neurol Neurosurg Psychiatry. 2004 May;75(5):696-9.

18.
19.

Apolipoprotein E deficiency increased microglial activation/CCR3 expression and hippocampal damage in kainic acid exposed mice.

Duan RS, Chen Z, Dou YC, Concha Quezada H, Nennesmo I, Adem A, Winblad B, Zhu J.

Exp Neurol. 2006 Dec;202(2):373-80. Epub 2006 Aug 17.

PMID:
16919271
20.

Apolipoprotein E alleles and brain vascular pathology in Alzheimer's disease.

Kalaria RN, Cohen DL, Premkumar DR.

Ann N Y Acad Sci. 1996 Jan 17;777:266-70.

PMID:
8624096

Supplemental Content

Support Center